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Medication therapy management
services (MTMS) have been shown to
improve patient health outcomes through
improved control of chronic disease and more
careful attention to potential drug-drug
interaction, Insurers have found MTMS to be
quite effective at both cost and patient risk
reduction, Both patients and pharmacists
have a generally positive outlook on the
MTM process; however, many pharmacists
muggle to balance their current clinical
responsibilities with the added workload of
MTMS, This study was conducted to identifY
the barriers to MTMS provision encountered
by Indiana pharmacists,

LITERATURE REVIEW
MTMS became a required service as
part of the Medicare Modernization Act of
2003 (MMA) , This piece of legislation
requires all Medicare Part D prescription
drug plan sponsors (PDPS) to create a
medication therapy management program
for targeted patients in order to improve
overall knowledge of medication usage
(American Society of Health System
Pharmacists, 2006), According to Medicare,
individuals who are "targeted" to receive
MTMS are those who have multiple chronic
rliseases (such as diabetes, asthma,
hypertension, etc,), have been prescribed
several covered Part D medications, and are
Second Quarter 2008

paying at least $4,000 in out-of-pocket
expenses for their medication each year
(American Society of Health Systems
Pharmacists, 2006),
Insurance companies are eager to
implement programs to assist patients in
managing their medications because it is a
relatively small investment which has been
demonstrated to save a significant amount of
money, For example, Hahn and Shapiro
(2007) point out the cost differential between
patients with well-controlled diabetes versus
diabetes patients whose condition is not under
control. Even though the former patient
might require the insurer to pay more for
additional prescription drugs to keep the
diabetes controlled, the total treatment cost
for the controlled patient is between $8,000
and $13,000 lower per year than the
uncontrolled patient, These savings, largely a
result of MTM intervention by pharmacists,
are primarily due to the reduction of
potentially expensive complications for those
with uncontrolled diabetes, Insurance plans
have the freedom to establish fees involved in
providing MTMS, According to the Center
for Medicaid and Medicare Services (2006),
Medicare has mandated that potential Part D
sponsors provide explanation as to how
expended resources and time have been
factored into the reimbursement amount
requested by MTM providers,

Touchette, Burns, Bough, & Blackburn
(2006) suggest that one potential
problematic area involves the eligibility
restrictions for MTM services, They state:
"although an economic incentive may be
perceived in some cases", the fiscal impact
of.. ,an MTM program may depend less on
the condition being treated and more on the
potential of the involved medications to
result in benefit or cause harm" (p, 688),
Thus, to truly be effective, insurance
programs may need to restructure their
eligibility requirements to include more
chronic conditions based upon medication
risks, rather than limiting patients' eligibility
simply in terms of how "costly" their specific
condition may become,
Similarly, Cameron (2005) touches
on this same topic of patient "targeting,"
suggesting that some MTMS may lead to
improved patient compliance with drug
therapy, thereby creating less profitability
for the insurance companies because of
increased prescription expenses, To help
combat this potential problem of
insurance companies becoming too
exclusive with patient selection for
MTMS, Cameron suggests that physicians
and other healthcare professionals be
authorized to refer high-risk patients who
may not meet the established criteria to
receive MTM interventions,
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Regarding effectiveness, Touchette et al.
(2006) also mention that programs offering
a comprehensive list of services may be able
to better identify problem areas and
subsequently find solutions to those issues
via contact with the patient's physician
and/or multiple MTM progress visits. The
Center for Medicare and Medicaid Services
(2006) notes that insurance plans initially
will have the opportunity to choose the
design of their programs using any means of
communication, although they do suggest
that future regulations may be implemented
if particular methods of performing MTMS
prove more effective than others.
There is no doubt that patients are
taking advantage of MTM opportunities.
While some patients have low expectations
regarding pharmacy services and only wish
to be assured that they have the correct
medication (Summary, 2005), many seem
ready and willing to take advantage of these
consultation sessions with trusted medical
professionals (Lipowski, 2007; Swidan,
Mitzrzyk, & Samuels, 2007).
Pharmacists also believe that MTM
programs are beneficial, as they move
pharmacies in the direction of giving
practitioners official documentation of their
consultation time. Breeman (2007) noted
that "Managed care pharmacists want a
closer, more personal relationship with their
patients and to do what they truly love to
do" (p. 52). Pharmacist Ernest Dole,
explaining the need for a formal recognition
of services, notes that" ... most pharmacists
do not typically bill for the patient care
services they provide. And without
substantial development of that ability, the
profession's survival may be threatened"
(Sipkoff, 2007, para. 4). Furthermore,
MTM interventions may take longer than
expected, but the results are promising: "I
think
it's
rewarding
for
the
patients ... They're happy, and they know
there is somebody they can go to" (Gowda
& Provost, 2005, p. 1646).
Pharmacists with MTMS experience
affirm that the services increase patient
compliance and confidence because
medications are being administered
correctly. However, they also note that
MTMS also present conflicts of interest in
terms of funding and coordinating care
with other professionals (Gowda &
Provost, 2005). The bottom line is that "the
value of pharmacists as providers of patient
care services such as MTM
is
underappreciated" (Swidan, Mitrzyk, &
Samuels, 2007, p. 677). The authors, all

pharmacists themselves, recognize MTM as
a valuable program but insist that
pharmacists must "take immediate, decisive
steps toward demonstrating their value to
employers, insurance companies, and
government officials" (p. 677). Paul (2007)
underscores the importance of recognition,
noting that pharmacies must fairly
compensate for the additional time and
effort put forth by pharmacists.
Recent research has shown that
pharmacists are eager to implement
MTMS, but are counting on Medicare Part
D Prescription Drug Plans (PDPs) to assist
in
both
implementation
and
reimbursement logistics (Boyd, Boyd, &
Zillich, 2006). Of particular concern is lack
of commitment to face-to-face meetings one study reported that telephone centers
and mail campaigns comprised more than
half of the PDP provisions (Boyd, Boyd, &
Zillich, 2006). For many pharmacists, the
motivation is present, but more precise
definitions and guidelines regarding their
MTMS are needed.
The purposes and benefits of
medication therapy management (MTM)
have been well documented. Assuming
proper implementation, MTMS present
myriad benefits for pharmacists, patients,
physicians, and the pharmacy profession as a
whole. MTMS function to ('ensure
appropriate use of [Medicare] Part D drugs
to optimize therapeutic outcomes through
improved medication use and to reduce the
risk of adverse events including drug-drug
interactions" (Altman, 2007). Additionally,
MTMS are designed to "improve care,
enhance communication among patients
and providers, improve collaboration
among providers, and optimize medication
use for improved patient outcomes"
(APhA/NACDS Foundation, 2005).
Scholars have recently begun to
empirically demonstrate the benefits of
MTM in terms of improved patient
outcomes. Bunting and Cranor (2006)
tracked clinical, economic, and humanistic
outcomes of a recently implemented MTM
program for asthma patients over a five-year
period. They discovered that 70 percent of
patients had improved breathing rates
following the program. As far as economic
savings, an average of $1,230/patient/year
savings in indirect costs in terms of
workplace absenteeism (physically missing
work) and presenteeism (being at work but
unable to perform due to health condition)
were found. For humanistic outcomes, the
categories of shortness of breath, tightness of

chest, chest pains, and coughing/wheezing
all showed significant improvement upon
follow-up visits.
The pharmaceutical industry as
a whole stands to gain from the
implementation and execution of MTMS.
Pharmacy professionals have had a hard
time shedding their "behind-the-counter
persona," (Bari & Davis, 2007, p. 2), and
MTMS provide for more one-on-one
contact with customers, thereby reducing
the physical and psychological distance
and
patients,
between pharmacists
ultimately resulting in the degree of open
communication needed for effective drng
therapy. Pharmacies, because they are the
most visited health-care setting, are the most
appropriate place for MTMS to be rendered;
hence, pharmacists are in the best position to
administer the one-on-one communication
that MTMS warrant (Cranor, Bunting, &
Christiansen, 2003).
MTM is an opportunity for
pharmacists to demonstrate their in-depth
knowledge of the nuances of drug therapy.
Most physicians simply do not have the
time, and allied health care professionals
(i.e., Nurse Practitioners and Physician
Assistants) lack the clinical background
required for such interventions (Gebhart,
2004). Pharmacists have the responsibility
(and opportunity) to "step outside their
pharmacy box, educate the public and the
medical profession, and market their
services" (Schuh, 2008, p. 1).
With all of the benefits and opportunities
of MTMS, they are not without their
criticisms and drawbacks. Often, the sheer
volume of work required of pharmacists may
eliminate any extra time for these types of
services (Altman, 2007). These situations may
lead to the outsourcing of MTMS to other
pharmacists outside of the immediate
pharmacy setting. This scenario seems to run
contrary to the hope that MTMS would
bridge the gap between pharmacists and
of
expanding
patients
in
terms
communication and developing relationships.
Some of the tremendous opportunities
MTMS present can also be viewed as extra
pressure on pharmacists. Indeed, pharmacists
assume great responsibility that scholars
recognize: "the onus of popularizing the
development of quality MTMS now falls
squarely on the shoulders of the pharmacist"
(Bari & Davis, 2007, p. 8) .
Furthermore, skeptics fear that MTMS
may not be a revenue-generating activity and
will ultimately create a divide between
pharmacists administering the MTMS and
Second Quarter 2008

the prescrIptIOn drug plan sponsors who
design and manage the benefits (Cantwell,
2005). A lack of standardization of what
MTMS entail is also a salient concern. This
includes an unclear definition of what
should be included in MTMS, a lack of
understanding about the process of
reimbursement, and unclear expectations
about which patients should receive the
services.
A number of studies have been
conducted to identifY possible barriers to the
provision of MTM services based on the
observation that many pharmacists express
positive feelings about MTMS but largely
fail to provide these interventions. Several
factors have been identified that may explain
this inconsistency. One study found that
many pharmacists reported lack of
confidence regarding their ability to
successfully complete the patient care
involved in MTMS (Odedina, Segal,
Hepler, Lipowski, & Kimberlin, 1996).
Another study identified the physical layout
of stores and space allocated for pharmacyrelated services to be a potential barrier to
MTMS provision. Pharmacists without
access to private consultation rooms may
avoid MTMS and other patient interaction
due to privacy concerns (Raisch, 1993). This
barrier has become even more of an issue as
new HIPAA guidelines enforce the
of
patient
health
confidentiality
information. This study also identified
numerous barriers related to dealing with
prescribing physicians. Perceived barriers
included difficulty making contact due to
physician/pharmacist mutual availability
and negative physician attitudes toward
pharmacists' recommendations. Whether
these barriers are real or only perceived, they
serve to effectively reduce the amount of
pharmaceutical services provided in the
pharmacy.
A number of studies have recognized
insufficient reimbursement as a barrier. In a
comprehensive study of payment structures
for MTM sessions, the Lewin Group found
$1.00 to $2.00 per minute to be an adequate
figure to cover pharmacist labor costs
involved in providing MTMS. Total costs,
according to industry estimates, are higher,
at $2.00 to $3.00 per minute (Lewin Group,
2005). The amounts that state Medicaid
programs pay for MTMS vary. For example,
Iowa Medicaid pays $75.00 for an initial
assessment, $40.00 for a new problem or
follow-up assessment, and $25.00 for any
preventative follow-up assessments. In
contrast, Mississippi and Wisconsin
First Quarter 2008

Medicaid pay $20.00 and $40.11 per visit,
respectively. In many cases, these
reimbursement amounts do not cover the
costs of pharmacists who are providing the
services, and thus create a real barrier to the
implementation and execution of successful
programs.
Another study found that some
pharmacists employed by chain pharmacies
believed they should receive some of the
reimbursement that their stores receive for
their interventions (Rochester & Currey,
1999). Pharmacists who hold this opinion
are less likely to conduct MTM
interventions if they believe it creates
additional work with little individual
benefit.

METHOD
Mter reviewing published studies and
general descriptions about pharmacy
practices and patient care services, a 24-item
scale was developed to measure pharmacist
attitudes and practices surrounding MTMS
as well as to assess the presence and severity
of various predicted barriers. In addition to
these Likert-scale questions, a pool of
demographic and pharmacy characteristic
questions were included to assess other
characteristics which might be related to
MTMS provision. Finally, several openended questions were developed to solicit
unstructured feedback about pharmacists'
perceptions of MTMS. This questionnaire
was distributed to Indiana pharmacists via
the
Indiana
Pharmacist
Alliance
Community Pharmacy Academy e-mail list.
A total of 81 responses were collected from
practicing pharmacists in the state of
Indiana. Mter evaluating these responses, six
in-depth interviews were conducted to
further probe the nature of MTMS barriers.
From the survey responses and in-depth
interviews, nine barriers to MTMS
implementation in the state of Indiana
emerged.

RESULTS
Barl'iel' #1:
Lack of Management SUPP0l't
Research suggests that though MTMS
present tremendous opportunities for both
pharmacists and patients, they can also put
extra pressure on pharmacists. When lack of
time, training, structural resources, and
sufficient reimbursement are compounded
by little or no support from management,
the motivation and ability to provide
MTMS suffer. MTMS in all pharmacy
settings "should include structures

supporting
the
establishment
and
maintenance of the pharmacist-patient
relationship" (MTM in pharmacy practice,
2008), and management is at the core of
these structures. Lack of management
support is more of a roadblock than a barrier
- regardless of pharmacists' attitudes toward
MTMS, the feasibility of successful
implementation and maintenance rests on
continued management support. This claim
was supported by our survey: 100 percent of
pharmacists reporting lack of management
support for MTMS also reported that their
pharmacy did not provide MTMS.

Ba1'1'iel' #2:
Lack of Tmining
Based upon the literature review, we
expected to see lack of training as a barrier
for pharmacists' provision of MTMS. One
salient concern about MTMS was lack of
standardization. Many pharmacists believe
there is an ambiguous definition about what
comprises an MTM, exhibit a lack of
understanding about the process of
reimbursement, and possess unclear
expectations about who should receive
services. In short, because there is little
standardization of MTMS, pharmacists
lack the initial knowledge and clinical
practice to successfully perform requested
interventions.
From the survey, approximately 30
percent of our respondents reported having
no training in providing MTM services.
Similarly, 33 percent of respondents
reported that they were not well prepared in
school to conduct MTM services. These
responses demonstrate, in part, the training
gap pharmacists experience when beginning
to provide MTMS. If pharmacists are not
adequately informed, educated, and trained
in MTM provision, MTMS are not
rendered and patient care suffers. Several
interviewees noted that the "training" they
had received was informal, and oftentimes
"on-the-job." One interviewee stated:
"Much of my training has been practical,
and hands on, from experience, not so much
classroom training." A great number of
responses to the open-ended survey
questions demonstrate the significant role
training plays in the provision of MTMS.

Barl'iel' #3:
Inadequate Patient
Education and Awareness
While research has shown that patients
generally have a positive attitude toward
MTMS and that many are indeed taking
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advantages of these services, our survey and
interviews indicate room for improvement
in patient education. As expected, MTMS
are believed to improve the quality of
customer care, and only 17 percent of
pharmacists surveyed felt their patients were
not open to MTMS. However, these results
do not necessarily indicate that patients are
not experiencing difficulty in understanding
the process or benefits of MTMS.

Barrier #4:
Lack of Time
Based on the literature review, lack of
time was expected to be a barrier to
provision of MTMS. Pharmacists have
consistently expressed feeling the pressure
of time constraints and the added
responsibility of MTM provision only adds
to the stress.
Our survey revealed that 59 percent of
respondents felt they lacked the time to
provide requested MTMS. An additional
14 percent remained neutral on the issue
of time. Approximately 30 percent of
the responses to the open-ended survey
question regarding why MTMS were
not currently being provided included
comments referencing time as a barrier.

Barrier #5:
Lack of Private Space
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Concerns about patient confidentiality
in light of HIPAA requirements are salient
concerns for many pharmacists. The
physical layout of stores and space allocated
for pharmacy-related activity was found
by one study to be a perceived barrier
by pharmacists due to a lack of privacy.
Furthermore, current layouts of most
pharmacies are not conducive to the
comfortable climate necessary for open
dialogue in which the patient can feel free to
ask questions. Pharmacists without access to
private consultation rooms may avoid
MTMS and other patient interaction due to
privacy concerns (Raisch, 1993).
Our survey supported the published
literature related to this barrier. Of our
respondents, 45 percent reported lack of
private space for consultation was a barrier
to providing MTM services.

Barrier #6:
Complexity of Required
Documentation
A common mantra in many fields of
health care is "if you didn't document it,
you didn't do it." Pharmacists have
experience maintaining prescription records,

but many lack experience documenting
patient care activities. More comprehensive
documentation practices are essential when
pharmacists implement patient care services,
including MTM. Based on our literature
review and primary research, the complexity
of required MTMS documentation for the
service and for reimbursement has been
identified as a barrier.
Of survey respondents, 41 percent
reported
that
the
documentation
requirements for MTMS services are a
burden. Similarly indicating a problem with
the required documentation, 39 percent of
respondents indicated that they often
provide requested MTMS services without
completing the documentation required for
reimbursement.
In the survey, pharmacists expressed
that "documentation needs to be automated,
perhaps scan a bar code to identify the
medication/patient, and then use a touch
screen to verify the proper information was
covered." Respondents wished there was
"easier paperwork to complete, more time to
take care of monthly patient[s]."

delays in being able to speak to physician, or
problems with messages being incorrectly
relayed or ignored by nursing staff. This
difficulty in connecting with physicians
ultimately reduces pharmacists' willingness
to conduct MTM and other clinical
pharmacy services that require coordination
with other health professional.
In terms of collegiality, many
pharmacists reported being treated as
"second class citizens" in the healthcare
industry. Rather than being treated as an
integral part of a healthcare system,
pharmacists' efforts are often rebuffed by
physicians. One respondent reported being
told by a physician: "You don't need to do it
(MTM) for my patients - they know all they
need to do." Part of this lack of collegiality
may be due to physicians feeling threatened
by pharmacists' therapy suggestions. One
pharmacist remarked "It's kind of a 'turf'
thing: when I start making suggestions, they
[physicians] might feel like you're stepping
on toes."

Barrier #7:
Difficulty Interacting
With Physicians

Overall, access to information in the
provision of MTMS has been given little
attention in the pharmacy literature.
However, Raisch (1993) found that
pharmacists cite "inadequate patient
information" as a barrier to providing
MTMS. Another common concern reported
is lack of consistent and comprehensive
patient information, especially from patients
who trade at multiple pharmacies and see
multiple physicians. Despite attempts in the
literature to identify possible barriers early
on, lack of information remains an underresearched, unforeseen problem.
Results from our survey revealed that
60 percent of pharmacists do not believe
they have access to the necessary
information to provide MTMS. Based on
this result and the recommendations from
our interview respondents, it is clear that
increasing the amount of information
available to pharmacists will increase
pharmacists' levels of comfort with
recommending drug therapy modifications.
Without access to the same information,
physicians and pharmacists are unable to
provide consistent, quality care.

The results of our study were consistent
with the investigations conducted by Raisch
(1993) in terms of difficulty interacting with
primary care physicians. Similar to Riasch's
findings, pharmacists in Indiana reported
difficulty making contact with prescribing
physicians due to schedule availabilities, and
many reported that physicians often have a
negative view of pharmacists as part of a
patient's overall healthcare team.
From the survey, nearly 37 percent of
respondents reported experiencing difficulty
interacting with customers' primary care
physicians. Nearly 23 percent of respondents
were unsure when asked about difficulty
interacting with physicians, which may
indicate that some physicians and practices
are easier to contact and collaborate with
than others. A number of comments from
the open-ended questions provided more
insight into the day-to-day difficulties
pharmacists may encounter when dealing
with primary care physicians.
Based on these comments and
additional information received from
the interview, two primary areas of
concern were identified: communication
and collegiality. Pharmacists often have
difficulty communicating with primary care
physicians. Many respondents reported long

Barrier #8:
Lack of Access to InfOl'mation

Barrier #9:
Inadequate Reimbul'sement
Based on the literature review, this
barrier was expected, and it did prove to be
a significant barrier for the surveyed
Second Quarter 2008

,)harmacists, Many pharmacists expressed

~pinions consistent with Rochester

&

Currey's 1999 observation that pharmacists
are unlikely to conduct MTM interventions
if they believe it creates additional work with
little individual benefit,
From the survey, 14 percent of
pharmacists indicated that they did not
provide MTMS because compensation was
not adequate, A further 45 percent
remained unsure of their answer to this
question, This may indicate, at least
partially, a segment of the population that
does conduct MTMS but feels the

compensation is too low, or does
not conduct MTMS but is unwilling to
admit compensation is a factor, A
number of comments to the open-ended
questions reinforced the importance of
reimbursement for individual pharmacists,
This study sheds light on the
numerous barriers to the implementation
of MTMS encountered by Indiana
pharmacists, However, because of the
numerous benefits to pharmacists,
patients, and insurance companies alike,
steps must be taken to eliminate or reduce
the effects of these barriers,

This article is part

of a larger study

commissioned by the Indiana
Pharmacists Alliance and the
Purdue University School

of Pharmacy

PharmaTAP program, The full report
is available on the Indiana Pharmacists
Association web site,
indianapharmacists,org, The authors
wish to thank Dr, Christy Nash, Dr,
Melanie Morgan, and Heng Xu for
their assistance with this project. •
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